Blog - Senior Scientist and Technical Specialist Ashley Phillips, discusses a recent publication (Single-day protein LC–MS bioanalysis: can next-generation trypsins cut it?)
11 September 2023Blog - Here, we will summarize the eight essential characteristics of LC-MS/MS method validation, then explain why it is important that you work with an experienced contract research organization (CRO) to ensure quality in each of these areas: Accuracy Precision Specificity Quantification Limit Linearity Recovery Matrix Effect Stability
05 July 2023News - Resolian, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its 440m² analytical laboratory in Fordham, Cambridgeshire, UK.
30 June 2023News - Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development Solutions, Ltd. (acquired in 2022), today announced they will be operating under the new name Resolian — fully integrating the companies into one organization. This brings together the companies’ established bioanalytical laboratories and experts in the U.S., U.K., and most recently in Australia, as Resolian continues to expand and support the growing need for small and large molecule bioanalytical and analytical services globally.
17 May 2023Blog - Addressing ADC Regulatory Challenges by Providing Validated Assays for Multi-Domain Proteins
31 March 2023Blog - Accelerate timelines, lower costs, and ensure quality for your clinical research in Australia. Our advanced scientific infrastructure and world-class experts attract trials from across the globe and meet their needs with the highest standards and efficient regulatory requirements. Explore the extensive benefits of Australia’s clinical research ecosystem >
08 March 2023Blog - In the 2023 Quarter 1 issue of RQA (Research Quality Association) 2023 Q1 Quasar magazine, John Cheshire, our Senior QA Validation Officer discusses why the industry should be adopting risk-based CSV.
23 February 2023News - The Analytical and Materials Science (AMS) team has experienced significant growth since its inception 11 years ago and have outgrown their current lab space. To meet this rising demand, we have started work on reimagining an empty area of our site into a new state-of-the-art AMS laboratory. This lab will be over 30% larger, providing over 440 square metres of dedicated space for analytical and materials science work.
20 February 2023Blog - One of the biggest challenges faced by the bioanalytical sector is the lack of a true reference material. As a result, in most assays, an alternative commercially available therapeutic (for example, an enzyme replacement therapy (ERT) product) can be used as a surrogate for the transgene enzyme. This webinar discusses approaches taken in order to monitor the concentration of the expressed transgene product and any associated immunogenicity.
10 February 2023Blog - As a CRO, meeting client expectations can be an ongoing challenge. What can organisations do to make sure their research is as effective and efficient as possible? In the Autumn 2022 issue of European Pharmaceutical Contractor magazine, the leadership team from Alliance Pharma reviews what CRO organisations can do to make sure their research is as effective and efficient as possible while meeting the ongoing challenge of their customer's expectations.
27 January 2023